Born from a healthcare spin-off of 3M Company (MMM), the Eagan, Minnesota-based Solventum Corporation (SOLV) develops a wide range of medical products, dental solutions, and healthcare software. The ...
The company guided to an organic sales growth range of 2% to 3% for 2026, translating to 3% to 4% excluding an estimated 100 basis point impact from SKU exits. Hanson stated that the Acera acquisition ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Hosted on MSN
Solventum raises 2025 EPS guidance to $5.80-$5.95 with sales growth outlook up to 3% as transformation gains momentum
CEO Bryan C. Hanson stated that "we are continuing where we left off in Q1, delivering another solid quarter. And as a result of this positive momentum and strong execution, we are raising our sales ...
Shares of healthcare solutions provider Solventum (NYSE:SOLV) fell 6.5% in the morning session after the company reported weak fourth quarter results: its full-year EPS guidance missed. On the other ...
Solventum has a few good businesses, but the market is treating it as a complicated company. Its main parts are MedSurg, Dental, HIS, and a smaller Water / All Other. The thesis says the stock looks ...
Solventum Corporation (NYSE:SOLV) is one of the cheap new stocks to buy now. On February 26, Solventum reported Q4 2025 financial results that exceeded expectations, despite a reported sales decline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results